Back to results
US 2023/0416286 A1Published application
Inhibitors of mek kinase
AssigneeKinnate Biopharma Inc.
InventorsToufike KANOUNI, Robert S. KANIA, Jason M. COX
Life of this patent
Estimating the term…
Abstract
Provided herein are inhibitors of MEK kinase, pharmaceutical compositions comprising said inhibitory compounds, and methods for using said MEK kinase inhibitory compounds for the treatment of disease.
Claims17
1-39. (canceled)
A compound, or pharmaceutically acceptable salt or solvate thereof, selected from the group consisting of:
- 1-(3-((2-Fluoro-4-iodophenyl)amino)pyridin-4-yl)phospholane 1-oxide;
- 4-(Diethylphosphoryl)-N-(2-fluoro-4-iodophenyl)pyridin-3-amine;
- 4-(Dimethylphosphoryl)-N-(2-fluoro-4-iodophenyl)pyridin-3-amine;
- N-(2,3-Difluoro-4-iodophenyl)-4-(dimethylphosphoryl)pyridin-3-amine;
- 4-[Ethyl(methyl)phosphoryl]-N-(2-fluoro-4-iodophenyl)pyridin-3-amine;
- (R)-4-[Ethyl(methyl)phosphoryl]-N-(2-fluoro-4-iodophenyl)pyridin-3-amine;
- (S)-4-[ethyl(methyl)phosphoryl]-N-(2-fluoro-4-iodophenyl)pyridin-3-amine;
- N-(4-Bromo-2-fluorophenyl)-4-(dimethylphosphoryl)pyridin-3-amine;
- N-(4-bromo-2-fluorophenyl)-4-(diethylphosphoryl)pyridin-3-amine;
- 1-(3-((4-Bromo-2-fluorophenyl)amino)pyridin-4-yl)phospholane 1-oxide;
- 5-Chloro-4-(dimethylphosphoryl)-N-(2-fluoro-4-iodophenyl)pyridin-3-amine;
- (3-((4-Ethynyl-2-fluorophenyl)amino)pyridin-4-yl)dimethylphosphine oxide;
- 1-(3-((4-Ethynyl-2-fluorophenyl)amino)pyridin-4-yl)phospholane 1-oxide;
- N-(4-Bromo-2-fluorophenyl)-4-[(R)-ethyl(methyl)phosphoryl]pyridin-3-amine;
- N-(4-Bromo-2-fluorophenyl)-4-[(S)-ethyl(methyl)phosphoryl]pyridin-3-amine;
- 4-(Diethylphosphoryl)-N-(4-ethynyl-2-fluorophenyl)pyridin-3-amine;
- 4-[(R)-Ethyl(methyl)phosphoryl]-N-(4-ethynyl-2-fluorophenyl)pyridin-3-amine;
- 4-[(S)-Ethyl(methyl)phosphoryl]-N-(4-ethynyl-2-fluorophenyl)pyridin-3-amine;
- (2-Fluoro-5-((2-fluoro-4-iodophenyl)amino)pyridin-4-yl)dimethylphosphine oxide;
- 4-(Dimethylphosphoryl)-N-(4-iodophenyl)pyridin-3-amine;
- N-(4-Cyclopropyl-2-fluorophenyl)-4-(dimethylphosphoryl)pyridin-3-amine;
- 4-(Dimethylphosphoryl)-5-fluoro-N-(2-fluoro-4-iodophenyl)pyridin-3-amine;
- (2-Fluoro-3-((2-fluoro-4-iodophenyl)amino)pyridin-4-yl)dimethylphosphine oxide;
- N-(4-bromo-2-chlorophenyl)-4-(dimethylphosphoryl)-5-fluoropyridin-3-amine;
- N-(4-bromo-2-chlorophenyl)-4-(dimethylphosphoryl)pyridin-3-amine;
- N-(4-Bromo-2-chlorophenyl)-5-chloro-4-(dimethylphosphoryl)pyridin-3-amine;
- (3-((4-Bromo-2-fluorophenyl)amino)-5-chloropyridin-4-yl)dimethylphosphine oxide;
- 4-(Dimethylphosphoryl)-N-(2-fluoro-4-iodophenyl)-5-methylpyridin-3-amine;
- 4-(Dimethylphosphoryl)-N-(4-ethynyl-2-fluorophenyl)-5-fluoropyridin-3-amine;
- and
- (3-Chloro-5-((4-cyclopropyl-2-fluorophenyl)amino)pyridin-4-yl)dimethylphosphine oxide.
28 more elements
A pharmaceutical composition comprising a compound, or pharmaceutically acceptable salt or solvate thereof, selected from the group consisting of:
- 1-(3-((2-Fluoro-4-iodophenyl)amino)pyridin-4-yl)phospholane 1-oxide;
- 4-(Diethylphosphoryl)-N-(2-fluoro-4-iodophenyl)pyridin-3-amine;
- 4-(Dimethylphosphoryl)-N-(2-fluoro-4-iodophenyl)pyridin-3-amine;
- N-(2,3-Difluoro-4-iodophenyl)-4-(dimethylphosphoryl)pyridin-3-amine;
- 4-[Ethyl(methyl)phosphoryl]-N-(2-fluoro-4-iodophenyl)pyridin-3-amine;
- (R)-4-[Ethyl(methyl)phosphoryl]-N-(2-fluoro-4-iodophenyl)pyridin-3-amine;
- (S)-4-[ethyl(methyl)phosphoryl]-N-(2-fluoro-4-iodophenyl)pyridin-3-amine;
- N-(4-Bromo-2-fluorophenyl)-4-(dimethylphosphoryl)pyridin-3-amine;
- N-(4-bromo-2-fluorophenyl)-4-(diethylphosphoryl)pyridin-3-amine;
- 1-(3-((4-Bromo-2-fluorophenyl)amino)pyridin-4-yl)phospholane 1-oxide;
- 5-Chloro-4-(dimethylphosphoryl)-N-(2-fluoro-4-iodophenyl)pyridin-3-amine;
- (3-((4-Ethynyl-2-fluorophenyl)amino)pyridin-4-yl)dimethylphosphine oxide;
- 1-(3-((4-Ethynyl-2-fluorophenyl)amino)pyridin-4-yl)phospholane 1-oxide;
- N-(4-Bromo-2-fluorophenyl)-4-[(R)-ethyl(methyl)phosphoryl]pyridin-3-amine;
- N-(4-Bromo-2-fluorophenyl)-4-[(S)-ethyl(methyl)phosphoryl]pyridin-3-amine;
- 4-(Diethylphosphoryl)-N-(4-ethynyl-2-fluorophenyl)pyridin-3-amine;
- 4-[(R)-Ethyl(methyl)phosphoryl]-N-(4-ethynyl-2-fluorophenyl)pyridin-3-amine;
- 4-[(S)-Ethyl(methyl)phosphoryl]-N-(4-ethynyl-2-fluorophenyl)pyridin-3-amine;
- (2-Fluoro-5-((2-fluoro-4-iodophenyl)amino)pyridin-4-yl)dimethylphosphine oxide;
- 4-(Dimethylphosphoryl)-N-(4-iodophenyl)pyridin-3-amine;
- N-(4-Cyclopropyl-2-fluorophenyl)-4-(dimethylphosphoryl)pyridin-3-amine;
- 4-(Dimethylphosphoryl)-5-fluoro-N-(2-fluoro-4-iodophenyl)pyridin-3-amine;
- (2-Fluoro-3-((2-fluoro-4-iodophenyl)amino)pyridin-4-yl)dimethylphosphine oxide;
- N-(4-bromo-2-chlorophenyl)-4-(dimethylphosphoryl)-5-fluoropyridin-3-amine;
- N-(4-bromo-2-chlorophenyl)-4-(dimethylphosphoryl)pyridin-3-amine;
- N-(4-Bromo-2-chlorophenyl)-5-chloro-4-(dimethylphosphoryl)pyridin-3-amine;
- (3-((4-Bromo-2-fluorophenyl)amino)-5-chloropyridin-4-yl)dimethylphosphine oxide;
- 4-(Dimethylphosphoryl)-N-(2-fluoro-4-iodophenyl)-5-methylpyridin-3-amine;
- 4-(Dimethylphosphoryl)-N-(4-ethynyl-2-fluorophenyl)-5-fluoropyridin-3-amine;
- and
- (3-Chloro-5-((4-cyclopropyl-2-fluorophenyl)amino)pyridin-4-yl)dimethylphosphine oxide;
- and at least one pharmaceutically acceptable excipient.
29 more elements
Dependencies are inferred from the claim text.